Skip to content

13F-HR filed by Bronte Capital Management Pty Ltd.

Bronte Capital Management Pty Ltd. filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-04-13, with 17 holding rows worth $881,649,000.

Accession
0001471085-21-000003
Filed
2021-04-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 17 entries on the cover page, a total value of $881,649,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $881,649,000 with VALUE read as thousands by filing date, 13F file number 028-19143. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares Russell 2000 ETF464287655SHS98,400$218,499,000thousands by filing datecall
Berkshire Hathaway Inc084670702COM427,704$109,266,000thousands by filing date
Alphabet Inc. Reg. Shares A02079K305COM48,493$100,018,000thousands by filing date
HERBALIFE LTDG4412G101COM SHS2,120,559$94,068,000thousands by filing date
INTERACTIVE BROKERS GROUP INC COM CL A45841N107Stock853,951$62,373,000thousands by filing date
ISHARES TR464287648RUS 2000 GRW ETF175,000$52,630,000thousands by filing datecall
Visa Inc92826C839COM209,360$44,328,000thousands by filing date
SPY78462F103SHS9,900$39,332,000thousands by filing datecall
CORTEVA INC COM22052L104Stock824,656$38,445,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock59,387$28,098,000thousands by filing date
BANK OF NY MELLON CORP COM064058100Stock498,663$23,582,000thousands by filing date
STATE STR CORP COM857477103Stock268,980$22,597,000thousands by filing date
Altria Group Inc02209S103COM287,909$14,729,000thousands by filing date
Alphabet Inc. Reg. Shares C02079K107COM6,992$14,464,000thousands by filing date
NEWMONT CORP651639106COM131,430$7,921,000thousands by filing date
GRAHAM HLDGS CO COM CL B384637104Stock13,941$7,841,000thousands by filing date
Merrimack Pharmaceuticals Inc590328209Common / Ordinary Stock550,679$3,458,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001471085-21-000003this filing2021-04-13acceptance time not in the bulk data set